GRDN: Wall Street Initiates, Options Sour Before May Earnings

Guardian Pharmacy Services is collecting analyst buy ratings while options traders load up on puts. The divergence sharpens with earnings just one week away.

Analysts Build Conviction

B of A Securities initiated coverage on April 27 with a Buy and a $42 target. That follows Truist Securities raising its target to $43 from $38 on April 13. Jefferies initiated with a Buy and a $44 target in late March. All five analysts covering the stock rate it Buy, with a consensus target of $40.83. The stock closed at $37.57 on April 29 — about 9% below that mean target.

The bull case centres on Guardian's position in long-term care pharmacy, a fragmented market where the company's high-touch model and clean balance sheet give it room to grow through acquisition.

Options Tell a Different Story

The put-call ratio stands at 4.45 — well above its 20-day mean of 2.78. The ratio hit 5.79 on April 24, the highest reading since early April. With the 52-week high at 10.71, the current level is elevated but not extreme by GRDN's own history. Still, the directional message is clear: options traders are tilting heavily bearish into the May 6 earnings date.

Shorts Retreat, But Cost to Borrow Climbs

Short interest fell 13.6% over the past week to 7.03% of free float — roughly 2.55 million shares. The drop suggests some short sellers covered positions ahead of the print. Yet the cost to borrow jumped 147% week-over-week to 0.61%. That's an unusual combination. Availability remains wide, so the CTB spike reflects pricing pressure rather than a shortage of lendable shares.

The ORTEX short score sits at 57.4, down from 60.2 a week ago — consistent with the reduction in shorts outstanding.

Holder Landscape

The top holders tell their own story. Bindley Capital Partners trimmed 3.57 million shares as of late March. The CFO sold $5.6 million of stock on March 20. The CEO and co-founder Fred Burke sold $19.9 million the same day. Those sales came at $29.68 — the stock has since risen roughly 27% to $37.57.

BlackRock added 194,817 shares through March 31. Vanguard added 298,359.

What to Watch

Earnings land May 6. The past two prints produced a 5.2% one-day gain and a 1.1% one-day drop respectively — modest moves. The elevated put-call ratio suggests the options market is pricing in downside risk. Whether the analyst consensus or the options positioning proves correct should be clear by May 7.

---

Data summary

• SI % of FF: 7.03% (−13.6% w/w, +35.7% m/m)
• Cost to borrow: 0.61% (+147% w/w)
• Put-call ratio: 4.45 (20d mean: 2.78)
• Analyst consensus: 5 Buys, mean target $40.83
• Next earnings: May 6, 2026